Shareholder Structure
Intercell has a total of 48,480,486 issued shares of common stock, which includes 348,389 shares of treasury stock.
Intercell's major shareholder is Novartis Vaccines & Diagnostics (14.9 percent). GSK holds 1.9 percent of the shares. Intercell holds 0.7 percent of the shares issued as treasury stock and 0.6 percent are held by the management. The current free float is 81.9 percent.